Ranked #6,115 of 8,699 institutional investors
Diadema Partners LP
Morristown, NJ
$204M
US stock portfolio at live prices · today −$3.4M (−1.62%)
Live prices, last trade 10:49 AM ET
- Value at quarter end (Q3 2026)
- $219M
- Change from Q2 2026
- −$45.2M (−17.10%)
- Positions
- 71 · 30 new, 27 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: call options on $324M of stock, put options on $188M, $49.0M of convertible notes and other principal-amount securities. $7.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesUTHR 12.6%COGT 8.56%BMRN 7.64%ABVX 5.98%RVMD 5.64%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| UTHR United Therapeutics Corporation | 46,222 | $25.7M | 12.6% | Reduced −13% |
| COGT Cogent Biosciences, Inc. | 641,947 | $17.5M | 8.56% | Added +30% |
| BMRN BioMarin Pharmaceutical Inc. | 255,383 | $15.6M | 7.64% | Reduced −18% |
| ABVX ABIVAX Société Anonyme | 178,444 | $12.2M | 5.98% | Added +9% |
| RVMD Revolution Medicines, Inc. | 70,004 | $11.5M | 5.64% | Reduced −50% |
| VKTX Viking Therapeutics, Inc. | 433,166 | $11.1M | 5.43% | Reduced −2% |
| BBIO BridgeBio Pharma, Inc. | 103,960 | $8.0M | 3.93% | New |
| VRDN Viridian Therapeutics, Inc. | 257,076 | $7.9M | 3.89% | Added +157% |
| LQDA Liquidia Corporation | 120,000 | $6.7M | 3.26% | New |
| IMCR Immunocore Holdings plc | 221,764 | $5.9M | 2.88% | Reduced −13% |
| REPL Replimune Group, Inc. | 305,000 | $5.8M | 2.82% | New |
| JNJ Johnson & Johnson | 17,000 | $4.6M | 2.27% | Reduced −23% |
| FDMT 4D Molecular Therapeutics, Inc. | 421,107 | $4.5M | 2.20% | Reduced −26% |
| PCVX Vaxcyte, Inc. | 72,850 | $4.2M | 2.06% | Added +62% |
| KOD Kodiak Sciences Inc. | 38,991 | $3.9M | 1.89% | Reduced −82% |
| SUPN Supernus, Inc. | 117,512 | $3.4M | 1.68% | Added +74% |
| RYTM Rhythm Pharmaceuticals, Inc. | 30,000 | $3.4M | 1.67% | New |
| MBX MBX Biosciences, Inc. | 60,000 | $3.1M | 1.53% | New |
| INSM Insmed Incorporated | 18,497 | $2.7M | 1.32% | New |
| SLN Silence Therapeutics plc | 135,000 | $2.7M | 1.31% | New |
| RCUS Arcus Biosciences, Inc. | 153,810 | $2.5M | 1.21% | Reduced −31% |
| MNKD MannKind Corporation | 604,025 | $2.4M | 1.18% | Added +3,674% |
| CRVS Corvus Pharmaceuticals, Inc. | 204,811 | $2.0M | 0.97% | Reduced −31% |
| IVA Inventiva S.A. | 553,126 | $1.8M | 0.90% | Reduced −25% |
| BCRX BioCryst Pharmaceuticals, Inc. | 250,000 | $1.8M | 0.89% | New |
| EWTX Edgewise Therapeutics, Inc. | 44,346 | $1.8M | 0.88% | Reduced −84% |
| SPRB Spruce Biosciences, Inc. | 40,435 | $1.6M | 0.79% | Added +35% |
| TSHA Taysha Gene Therapies, Inc. | 422,619 | $1.6M | 0.77% | Reduced −19% |
| JBIO Jade Biosciences, Inc. | 91,259 | $1.4M | 0.69% | New |
| AMLX Amylyx Pharmaceuticals, Inc. | 53,152 | $1.4M | 0.68% | New |
| ORKA Oruka Therapeutics, Inc. | 13,169 | $1.3M | 0.61% | Reduced −53% |
| AVTX Avalo Therapeutics, Inc. | 181,947 | $1.2M | 0.61% | New |
| BCYC Bicycle Therapeutics plc | 398,869 | $1.2M | 0.58% | Reduced −14% |
| MLTX MoonLake Immunotherapeutics | 100,000 | $1.1M | 0.54% | New |
| RLMD Relmada Therapeutics, Inc. | 361,367 | $1.0M | 0.51% | Unchanged |
| VERA Vera Therapeutics, Inc. | 38,008 | $994K | 0.49% | Reduced −34% |
| PHAT Phathom Pharmaceuticals, Inc. | 179,950 | $880K | 0.43% | Added +38% |
| MLYS Mineralys Therapeutics, Inc. | 50,000 | $698K | 0.34% | Reduced −11% |
| SLS SELLAS Life Sciences Group, Inc. | 50,000 | $697K | 0.34% | New |
| LRMR Larimar Therapeutics, Inc. | 185,705 | $578K | 0.28% | Added +27% |
| CTNM Contineum Therapeutics, Inc. | 64,549 | $568K | 0.28% | Reduced −46% |
| TNGX Tango Therapeutics, Inc. | 25,000 | $560K | 0.27% | New |
| PTHS Pelthos Therapeutics Inc. | 80,760 | $549K | 0.27% | Added +226% |
| KARD Kardigan, Inc. | 43,972 | $537K | 0.26% | New |
| MGNX MacroGenics, Inc. | 262,059 | $535K | 0.26% | Reduced −30% |
| FULC Fulcrum Therapeutics, Inc. | 133,385 | $495K | 0.24% | New |
| QNRX Quoin Pharmaceuticals, Ltd. | 146,446 | $489K | 0.24% | New |
| NBP NovaBridge Biosciences | 500,000 | $484K | 0.24% | New |
| ELVN Enliven Therapeutics, Inc. | 10,000 | $468K | 0.23% | Unchanged |
| TRDA Entrada Therapeutics, Inc. | 100,000 | $447K | 0.22% | New |
| SMMT Summit Therapeutics Inc. | 41,887 | $429K | 0.21% | Reduced −30% |
| XENE Xenon Pharmaceuticals Inc. | 10,000 | $376K | 0.18% | New |
| NRIX Nurix Therapeutics, Inc. | 21,539 | $285K | 0.14% | Reduced −82% |
| TLPH Talphera, Inc. | 378,037 | $276K | 0.14% | Added +146% |
| AEMD Aethlon Medical, Inc. | 50,000 | $246K | 0.12% | New |
| ARDX Ardelyx, Inc. | 77,133 | $228K | 0.11% | Reduced −75% |
| AYTU Aytu BioPharma, Inc. | 67,186 | $178K | <0.1% | Reduced −55% |
| OCGN Ocugen, Inc. | 200,000 | $159K | <0.1% | Unchanged |
| ATTO Attovia Therapeutics, Inc. | 9,700 | $146K | <0.1% | New |
| ABEO Abeona Therapeutics Inc. | 51,117 | $125K | <0.1% | New |
| HRTX Heron Therapeutics, Inc. | 458,723 | $122K | <0.1% | Unchanged |
| LLY Eli Lilly and Company | 60 | $82K | <0.1% | New |
| PALI Palisade Bio, Inc. | 69,533 | $66K | <0.1% | New |
| CLRB Cellectar Biosciences, Inc. | 71,382 | $61K | <0.1% | Reduced −48% |
| TVRD Tvardi Therapeutics, Inc. | 48,491 | $45K | <0.1% | Added +192% |
| ENTA Enanta Pharmaceuticals, Inc. | 5,503 | $42K | <0.1% | New |
| ELTX Elicio Therapeutics, Inc. | 9,440 | $14K | <0.1% | New |
| OTLK Outlook Therapeutics, Inc. | 35,000 | $13K | <0.1% | New |
| MXCT MaxCyte, Inc. | 8,190 | $11K | <0.1% | New |
| APRE Aprea Therapeutics, Inc. | 28,872 | $9K | <0.1% | Reduced −36% |
| NTLA Intellia Therapeutics, Inc. | 124 | $1K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| NVO Novo Nordisk A/S | 100,000 | $3.9M |
| ZYME Zymeworks Inc. | 142,132 | $3.9M |
| RLAY Relay Therapeutics, Inc. | 230,677 | $3.7M |
| XERS Xeris Biopharma Holdings, Inc. | 132,746 | $2.2M |
| SYRE Spyre Therapeutics, Inc. | 15,000 | $1.4M |
| PEPG PepGen Inc. | 373,284 | $1.4M |
| UNCY Unicycive Therapeutics, Inc. | 303,676 | $1.1M |
| RIGL Rigel Pharmaceuticals, Inc. | 22,816 | $929K |
| HRMY Harmony Biosciences Holdings, Inc. | 26,864 | $893K |
| GLUE Monte Rosa Therapeutics, Inc. | 78,391 | $678K |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 301,264 | $667K |
| BIOA BioAge Labs, Inc. | 146,334 | $659K |
| VYGR Voyager Therapeutics, Inc. | 413,642 | $655K |
| PGEN Precigen, Inc. | 135,293 | $581K |
| RNAC Cartesian Therapeutics, Inc. | 87,057 | $538K |
| EQ Equillium, Inc. | 400,282 | $460K |
| DFTX Definium Therapeutics, Inc. | 15,451 | $449K |
| AMGN Amgen Inc. | 593 | $262K |
| CUE Cue Biopharma, Inc. | 48,369 | $209K |
| FHTX Foghorn Therapeutics Inc. | 66,908 | $117K |
| LAKE Lakeland Industries, Inc. | 14,108 | $114K |
| MNPR Monopar Therapeutics Inc. | 1,630 | $111K |
| ANNX Annexon, Inc. | 27,516 | $90K |
| NXTC NextCure, Inc. | 7,742 | $51K |
| KLRA Kailera Therapeutics, Inc. | 3,621 | $41K |
| UPB Upstream Bio, Inc. | 19,093 | $36K |
| SPRY ARS Pharmaceuticals, Inc. | 4,860 | $16K |